A vs REPL
Agilent Technologies Inc (A) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
Agilent Technologies Inc (A) is a diagnostics & research company listed on US.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported A revenue for 2024-10-31 was $6.51B. Net income was $1.29B. Revenue was down 4.7% from 2023-10-31 to 2024-10-31. A currently screens at market cap $33.70B and trailing P/E 29.2.
REPL does not have a complete income-statement cache yet.
A currently screens at market cap $33.70B and trailing P/E 29.2. REPL currently screens at market cap $825.7M.
Not investment advice. Open the A and REPL stock pages for the full models.
Not investment advice.